Pulmonary Medication Adherence and Health-care Use in Cystic Fibrosis
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Background Poor treatment adherence is common in cystic fibrosis (CF) and may lead to worse health outcomes and greater health-care use. This study evaluated associations of adherence to pulmonary medications, age, health-care use, and cost among patients with CF. Methods Patients with CF aged ≥ 6 years were identified in a national commercial claims database. A 12-month medication possession ratio (MPR) was computed for each pulmonary medication and then averaged for a composite MPR (CMPR) for each patient. The CMPR was categorized as low ( Results Mean CMPR for the sample (N = 3,287) was 48% ± 31%. Age was inversely related to CMPR. In the concurrent year, more CF-related hospitalizations were observed among patients with low (event rate ratio [ERR], 1.35; 95% CI, 1.15-1.57) and moderate (ERR, 1.25; 95% CI, 1.05-1.48) vs high adherence; similar associations were observed for all-cause hospitalizations and CF-related and all-cause acute care use (hospitalizations + ED) in the concurrent and subsequent year. Rates of CF-related and all-cause outpatient visits did not differ by adherence. Low and moderate adherence predicted higher concurrent health-care costs by $14,211 ($5,557-$24,371) and $8,493 (-$1,691 to $19,709), respectively, compared with high adherence. Conclusions Worse adherence to pulmonary medications was associated with higher acute health-care use in a national, privately insured cohort of patients with CF. Addressing adherence may reduce avoidable health-care…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Low adherence to all treatments is associated with an increased number of pulmonary exacerbations requiring intravenous (IV) antibiotics (Eakin 2011) and hospitalisations, which incur higher healthcare costs (Quittner 2014).”
From Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis (2023) · cites this paper as Quittner 2014
Citations
Cites
Physician Communication and Patient Adherence to Treatment: A Meta-Analysis
Haskard Zolnierek, K. B., & DiMatteo, M. R. (2009) · Medical Care · doi:10.1097/mlr.0b013e31819a5acc · Cited by 2,489
Patient Adherence and Medical Treatment Outcomes: A Meta-Analysis
Robin DiMatteo, M., Giordani, P. J., Lepper, H. S., & Croghan, T. W. (2002) · Medical Care · doi:10.1097/00005650-200209000-00009 · Cited by 1,490
Interventions to Enhance Patient Adherence to Medication Prescriptions: Scientific Review
McDonald, H. P., Garg, A. X., & Haynes, R. B. (2002) · JAMA · doi:10.1001/jama.288.22.2868 · Cited by 1,176
Cystic Fibrosis Pulmonary Guidelines: Chronic Medications for Maintenance of Lung Health
Flume, P. A., O'Sullivan, B. P., Robinson, K. A., Goss, C. H., Mogayzel, P. J., Willey-Courand, D. B., Bujan, J., Finder, J., Lester, M., Quittell, L., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-664oc · Cited by 1,024
A Controlled Trial of Long-Term Inhaled Hypertonic Saline in Patients with Cystic Fibrosis
Elkins, M. R., Robinson, M., Rose, B. R., Harbour, C., Moriarty, C. P., Marks, G. B., Belousova, E. G., Xuan, W., & Bye, P. T. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa043900 · Cited by 862
Cystic Fibrosis Pulmonary Guidelines: Chronic Medications for Maintenance of Lung Health
Mogayzel, P. J., Naureckas, E. T., Robinson, K. A., Mueller, G., Hadjiliadis, D., Hoag, J. B., Lubsch, L., Hazle, L., Sabadosa, K., Marshall, B., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201207-1160oe · Cited by 615
Kahana, S., Drotar, D., & Frazier, T. (2008) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsm128 · Cited by 334
How patient cost-sharing trends affect adherence and outcomes: a literature review.
Eaddy, M. T., Cook, C. L., O'Day, K., Burch, S. P., & Cantrell, C. R. (2012) · Europe PMC (PubMed Central) · Cited by 327
Barriers to Treatment Adherence for Children with Cystic Fibrosis and Asthma: What Gets in the Way?
Modi, A. C., & Quittner, A. L. (2006) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsj096 · Cited by 301
Self-citationA multi-method assessment of treatment adherence for children with cystic fibrosis
Modi, A. C., Lim, C. S., Yu, N., Geller, D., Wagner, M. H., & Quittner, A. L. (2006) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2006.03.002 · Cited by 265
Self-citationLongitudinal association between medication adherence and lung health in people with cystic fibrosis
Eakin, M. N., Bilderback, A., Boyle, M. P., Mogayzel, P. J., & Riekert, K. A. (2011) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2011.03.005 · Cited by 246
Self-citationRiekert, K. A., Bartlett, S. J., Boyle, M. P., Krishnan, J. A., & Rand, C. S. (2007) · Chest · doi:10.1378/chest.06-2474 · Cited by 197
Self-citationSmith, B. A., Modi, A. C., Quittner, A. L., & Wood, B. L. (2010) · Pediatric Pulmonology · doi:10.1002/ppul.21238 · Cited by 185
Self-citationSawicki, G. S., Ren, C. L., Konstan, M. W., Millar, S. J., Pasta, D. J., & Quittner, A. L. (2013) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.12.009 · Cited by 154
Self-citationModi, A. C., Marciel, K. K., Slater, S. K., Drotar, D., & Quittner, A. L. (2008) · Children's Health Care · doi:10.1080/02739610701766925 · Cited by 125
Self-citationGeorge, M., Rand-Giovannetti, D., Eakin, M. N., Borrelli, B., Zettler, M., & Riekert, K. A. (2010) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2010.08.016 · Cited by 118
Self-citationAdherence to treatment in children and adolescent patients with cystic fibrosis
Zindani, G. N., Streetman, D. D., Streetman, D. S., & Nasr, S. Z. (2005) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2004.09.013 · Cited by 117
Sawicki, G. S., Rasouliyan, L., McMullen, A. H., Wagener, J. S., McColley, S. A., Pasta, D. J., & Quittner, A. L. (2011) · Pediatric Pulmonology · doi:10.1002/ppul.21325 · Cited by 106
Self-citationAdherence with tobramycin inhaled solution and health care utilization
Briesacher, B. A., Quittner, A. L., Saiman, L., Sacco, P., Fouayzi, H., & Quittell, L. M. (2011) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-11-5 · Cited by 95
Self-citationPrevalence of symptoms of anxiety and depression in German patients with cystic fibrosis
Goldbeck, L., Besier, T., Hinz, A., Singer, S., & Quittner, A. L. (2010) · Chest · doi:10.1378/chest.09-2940 · Cited by 89
Self-citationTrajectories of adherence to airway clearance therapy for patients with cystic fibrosis
Modi, A. C., Cassedy, A. E., Quittner, A. L., Accurso, F., Sontag, M., Koenig, J. M., & Ittenbach, R. F. (2010) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsq015 · Cited by 72
Ball, R., Southern, K. W., McCormack, P., Duff, A. J. A., Brownlee, K. G., & McNamara, P. S. (2013) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.12.012 · Cited by 53
Modi, A. C., & Quittner, A. L. (2006) · Children's Health Care · doi:10.1207/s15326888chc3501_4 · Cited by 52
Self-citationNebulised dornase alpha: adherence in adults with cystic fibrosis
Burrows, J. A., Bunting, J., Masel, P. J., & Bell, S. C. (2002) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(02)00095-4 · Cited by 46
Adherence to dornase alfa treatment among commercially insured patients with cystic fibrosis
Nasr, S. Z., Chou, W., Villa, K. F., Chang, E., & Broder, M. S. (2013) · Journal of Medical Economics · doi:10.3111/13696998.2013.787427 · Cited by 44
Adherence to the medical regimen: clinical implications of new findings
Abbott, J., Havermans, T., & Hart, A. (2009) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e3283310859 · Cited by 31
Non-compliance in adolescents with chronic lung disease: causative factors and practical approach
Fitzgerald, D. A. (2001) · Paediatric Respiratory Reviews · doi:10.1053/prrv.2001.0149 · Cited by 27
Economic impact of tobramycin in patients with cystic fibrosis in a managed care population
Wertz, D. A., Chang, C., Stephenson, J. J., Zhang, J., & Kuhn, R. J. (2011) · Journal of Medical Economics · doi:10.3111/13696998.2011.621004 · Cited by 13
Self-citation
Research works printed but not linked: 2
- Pressler, 2011, Aztreonam for inhalation solution, an aerosolized antibiotic for the treatment of pseudomonal airway infection in patients with cystic fibrosis, US Res Dis, 7, 107
- Quinn, 2004, Measuring, predicting and improving adherence to inhalation in patients with CF: a randomised controlled study of motivational interviewing [abstract], Pediatr Pulmonol, 38, 360
Cited by
Economic impact of medication non-adherence by disease groups: a systematic review
Cutler, R. L., Fernandez-Llimos, F., Frommer, M., Benrimoj, C., & Garcia-Cardenas, V. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-016982 · Cited by 900
Ratjen, F., Bell, S. C., Rowe, S. M., Goss, C. H., Quittner, A. L., & Bush, A. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.10 · Cited by 546
Self-citationCFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
Lopes-Pacheco, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01662 · Cited by 535
Quittner, A. L., Goldbeck, L., Abbott, J., Duff, A., Lambrecht, P., Solé, A., Tibosch, M. M., Bergsten Brucefors, A., Yüksel, H., Catastini, P., et al. (2014) · Thorax · doi:10.1136/thoraxjnl-2014-205983 · Cited by 524
Self-citationBrazilian guidelines for the diagnosis and treatment of cystic fibrosis
Athanazio, R. A., Filho, L. V. R. F. D. S., Vergara, A. A., Ribeiro, A. F., Riedi, C. A., Procianoy, E. D. F. A., Adde, F. V., Reis, F. J. C., Ribeiro, J. D., Torres, L. A. G. M. M., et al. (2017) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37562017000000065 · Cited by 238
“These actions are essential, since adequate compliance with the actions inherent to the disease is related to relevant clinical benefits.(239-242)”
Background
Metadata
- Authors
- Quittner, A. L., Zhang, J., Marynchenko, M., Chopra, P. A., Signorovitch, J., Yushkina, Y., & Riekert, K. A.
- Affiliations
- University of Miami (US)
- Novartis (United States) (US)
- Analysis Group (United States) (US)
- Johns Hopkins University (US)
- Corresponding author
- Quittner, Alexandra L.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2014-07
- Volume
- 146
- Issue
- 1
- Pages
- 142-151
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2070450626
- Cited by
- 250
- References
- 28
- Citations by year
- 2026: 11 · 2025: 12 · 2024: 11 · 2023: 24 · 2022: 28 · 2021: 20 · 2020: 29 · 2019: 23 · 2018: 20 · 2017: 28 · 2016: 15 · 2015: 22 · 2014: 6
- FWCI
- 24.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- CHEST Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- cystic fibrosis, medication adherence, medication possession ratio, health care utilization, hospitalization, health care costs, outpatient visits, emergency department visits, age, privately insured patients
- MeSH terms
- Adolescent, Adult, Child, Cystic Fibrosis, Delivery of Health Care, Female, Follow-Up Studies, Humans, Immunosuppressive Agents, Male, Patient Compliance, Retrospective Studies, Health Care Costs, Disease Management, Medication Adherence, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.